EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis

Anum Saeed iD, Oscar Lopez iD, Ann Cohen iD, Steven E Reis

Journal of the American Heart Association · 07.11.2023 · 12 (21)

DOI: 10.1161/jaha.123.030780 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 07.11.2023. Verfasst von Anum Saeed und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh School of Medicine Pittsburgh PA USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cardiovascular Diseases. Die Arbeit wurde bisher 182-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality in aging adults across the United States. Prior studies indicate that the presence of atherosclerosis, the pathogenic basis of CVD, is linked with dementias. Alzheimer's disease (AD) and AD‐related dementias are a major public health challenge in the United States. Recent studies indicate that ≈3.7 million Americans ≥65 years of age had clinical AD in 2017, with projected increases to 9.3 million by 2060. Treatment options for AD remain limited. Development of disease‐modifying therapies are challenging due, in part, to the long preclinical window of AD. The preclinical incubation period of AD starts in midlife, providing a critical window for identification and optimization of AD risk factors. Studies link AD with CVD risk factors such as hypertension, inflammation, and dyslipidemia. Both AD and CVD are progressive diseases with decades‐long development periods. CVD can clinically manifest several years earlier than AD, making CVD and its risk factors a potential predictor of future AD. The current review focuses on the state of literature on molecular and metabolic pathways modulating the heart–brain axis underlying the potential association of midlife CVD risk factors and their effect on AD and related dementias. Further, we explore potential CVD/dementia preventive strategies during the window of opportunity in midlife and the future of research in the field in the multiomics and novel biomarker use era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCardiovascular DiseasesHumansUnited StatesBrainRisk FactorsInflammation

Stichwörter der Autor:innen

Alzheimer's diseaseatherosclerosisbrain biomarkerscardiac risk factorscardiovascular diseasecerebrovascular diseasedementia

Autor:innen und Institutionen

  • University of Pittsburgh School of Medicine Pittsburgh PA USA.
  • Heart and Vascular Institute University of Pittsburgh Medical Center PA Pittsburgh USA.
  • Cognitive and Behavioral and Neurology Division University of Pittsburgh Medical Center PA Pittsburgh USA.
  • Division of Psychiatry University of Pittsburgh Medical Center PA Pittsburgh USA.

ORCID-Profile: Anum Saeed, Oscar Lopez, Ann Cohen

Zitieren

APA

Saeed, A., Lopez, O., Cohen, A., & Reis, S. E. (2023). Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis. Journal of the American Heart Association, 12(21). https://doi.org/10.1161/jaha.123.030780

Vancouver

Saeed A, Lopez O, Cohen A, Reis SE. Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis. Journal of the American Heart Association. 2023;12(21). doi:10.1161/jaha.123.030780

BibTeX
@article{Saeed2023,
  author = {Saeed, Anum and Lopez, Oscar and Cohen, Ann and Reis, Steven E},
  title = {Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {21},
  doi = {10.1161/jaha.123.030780}
}
Kostenlos starten →